Replies to post #105656 on Regen BioPharma Inc (RGBP)

[29YEARINVESTOR]

Wrong!

https://www.biospace.com/article/releases/regen-biopharma-inc-to-initiate-development-of-its-modified-mrna-anti-cancer-vaccine-technology/

https://docoh.com/filing/1589150/0001607062-21-000077/RGBP-8K

Research programme: cancer therapeutics - Regen https://adisinsight.springer.com/drugs/800037634 drugs
This allows continual expression of mRNA-specific siRNA and direct inhibition of protein ... These data were published in two peer-reviewed articles in the ... google or
Spend the $50
notice the Latest Information Update: 15 Mar 2022 today!

As of 3-10-22 It’s also now very oblivious those that said Lander would never do business with RGBP. Where 100% Wrong!

https://www.yahoo.com/lifestyle/regen-biopharma-inc-announces-program-120000581.html

Dyo Biotechnologies ( https://www.dyobiotechnologies.com ) has been contracted to assist Regen with the development of the above mentioned technology.

Do we now have a Cornell deal without having to raise big Money?

Check out RGBP’s new contracted Team!
https://www.dyobiotechnologies.com/team/

Why did Lander also return shares while some claim he is owed money?
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=159268471

[Skiluc]

No trials? You should update your self.

Oopsie.

[Natureboy1]

It appears that denial ain’t just a river in Egypt. Go RGBP!